The Manila Times

Correction: JJP Biologics Announces Positive Top-Line Phase I Trial Results of JJP-1212, its anti-CD89 antagonist

Favorable safety, tolerability, pharmacokinetic and pharmacodynamic profiles validate and significantly de-risk the ...
The Manila Times

JJP Biologics Announces Positive Top-Line Phase I Trial Results of JJP-1212, its anti-CD89 antagonist

Favorable safety, tolerability, pharmacokinetic and pharmacodynamic profiles validate and significantly de-risk the ...

How Gen Z In India Is Driving The Rise Of Online Degrees

The rise of online degrees represents a long-term structural shift in Indian higher education. In India, this is fueled by ...